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INTRODUCTION 
Antibiotics are the most frequently prescribed drugs 
among hospitalized patients especially in intensive care 
and surgical department. Encouraging appropriate 
antibiotic prescriptions in health institutions is an 
important element in quality of care, infection control and 
cost containment1. The development of bacterial resistance 
to antibiotics has become a major problem throughout the 
world2. Antimicrobial resistance results in increased 
morbidity, mortality, and rising cost of health care 3,4. 
Monitoring of antimicrobial use and knowledge of 
prescription habits are some of the strategies recommended 
to contain resistance to antimicrobials in hospitalized 
patients. Our study focused in analyzing drug utilization 
pattern of Fluoroquinolones in the Medicine and Surgery 
wards of the hospital. 
MATERIALS AND METHODS: 
This study was carried out in the medicine and surgery 
wards of a 1000 bedded private tertiary care teaching 
hospital. The study was conducted for a period of seven 
months. Permission was obtained from Institutional Ethics 
Committee before starting the study. The data were 
collected from patients of all age groups from either sex, 
who got admitted to the medicine and surgery wards of the 
hospital. 
A suitable data collection form was designed to collect and 
document the data. Data collection form includes 
demographic details of patient; drug therapy details (name 
of drug, dosage form, frequency, route of administration, 
duration of treatment) and length of stay. Data were 
collected from the patient's file on a daily basis. 
Comparison of prescribed daily doses of FQs with defined 
daily doses was carried out using ATC/DDD Index 2013. 
The DDD/100 bed-days of all the FQs prescribed in the 
Medicine and Surgery ward was calculated. The DDD/100 
bed-days of the individual FQs were added together to get 
the total FQ consumption.  
The use of individual Fluoroquinolones and of the group as 
a whole was measured using the defined daily dose 
(DDD)/100 bed-days using the following formula
5
: 
 
DDD/100 bed-days =               No. of units administered in the study period (mg)  x   100                           
DDD (mg) x No. of days in study period x No. of beds x bed occupancy 
 
Data of all the patients were analyzed with the help of 
Microsoft Access Data Sheet version 2010.  
RESULTS: 
We have enrolled 100 patients in the study who, were 
prescribed with FQs during the study period. It includes 67 
males and 33 female patients. The majority of the patients 
(22%) were in the age group of 15-25 years followed by 
(19%) in the age group 56-65 years. The age wise 
distribution of the patients is presented in (Table 1). 
 
Table 1: Age Distribution of Study Population 
 
Age (years) No. of patients (n=100) 
15-25 22 
26-35 10 
36-45 14 
46-55 16 
56-65 19 
66-75 14 
76-85 5 
 
 
ABSTRACT 
It is well known that antibiotics are prescribed abundantly in hospitalized patients especially in critical care settings. The 
antibiotic usage will also vary depends on the type of therapy, physicians perceptions and availability of the drug. Our aim was 
to study the drug utilization pattern of Fluoroquinolone (FQs) antibiotics in medicine and surgery wards of a tertiary care 
hospital. A total of 100 patients who received FQs were enrolled in the study and the FQ utilization was measured in terms of  
DDD/100 bed days. Mean ± SD number of drugs prescribed and length of hospital stay were 8.23 ± 3.33 and 11.54 ± 7.57 
respectively. Ciprofloxacin was the most commonly prescribed drug. Overall Fluoroquinolone utilization was found to be 
33.55 DDD/100 bed-days.  
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A total of 823 drugs were prescribed. The mean ± SD of 
drugs prescribed was 8.23 ± 3.33. For an individual 
patient, a particular drug prescribed by different brand 
names and administered by different routes was taken as a 
single drug for the purpose of calculation. The maximum 
number of patients (67%) was admitted in the Medicine 
wards and rest (33%) was admitted in the Surgery wards. 
The number of drugs prescribed per patient is presented in 
(Table 2). 
Table 2: Number of Drugs Prescribed During the 
Period of Hospitalization 
S. N. Number of drugs in the 
prescription 
Number of patients 
received 
1 1-4 8 
2 5-8 51 
3 9-12 30 
4 13-16 10 
5 >16 1 
 
Twenty patients were admitted for a period of 1 to 5 days, 
37 patients for 6 to 10 days, 21 patients for 11 to 15 days, 
10 patients for 16 to 20 days, 5 patients for 21 to 25 days 
and 7 patients for greater than 25 days.  Mean ± SD 
duration of hospital stay was 11.54 ± 7.57 days. 
 Out of 100 patients 87 received FQs as monotherapy and 
13 patients received multiple drug therapy. The agents 
prescribed as monotherapy in large numbers were 
Ciprofloxacin (54.02%) followed by Levofloxacin 
(31.03%). The commonly prescribed multiple drug therapy 
was     Ciprofloxacin + Levofloxacin (53.84%). The details 
on the utilization of FQs as monotherapy and multiple drug 
therapy are presented in (Table 3 & 4). 
Table 3: Fluoroquinolones Prescribed as Monotherapy 
in Study Population 
Fluoroquinolones No. of patients 
(n=87) 
Percentage 
(%) 
Ciprofloxacin 40 45.98 
Levofloxacin 27 31.03 
Ofloxacin 12 13.79 
Norfloxacin 8 9.2 
 
 
Table 4: Fluoroquinolones Prescribed as Multiple Drug 
Therapy in Study Population 
Fluoroquinolones No. of patients 
(n=13) 
Percentage 
(%) 
Ciprofloxacin + 
Levofloxacin 
7 53.84 
Ciprofloxacin + 
Norfloxacin 
5 38.47 
Ciprofloxacin + 
Gemifloxacin 
1 7.69 
 
FQ usage in both the wards during the study period was 
calculated in terms DDD/100 bed-days. In our study 
DDD/100 bed-days for FQs was found to be 33.55. 
Ciprofloxacin was the most frequently prescribed FQ 
(15.72 DDD/100 bed-days), followed by Levofloxacin 
(12.54 DDD/100 bed-days). The ATC code and the 
DDD/100 bed-days of the prescribed FQs are presented in 
(Table 5). 
Table 5: ATC Code and DDD/100 Bed-Days of 
Fluoroquinolones Prescribed 
Drug Name ATC Code DDD/100 beddays 
Ciprofloxacin Oral J01MA 02 13.19 
Ciprofloxacin Parentral J01MA 02 2.53 
Levofloxacin Oral J01MA 12 9.426 
Levofloxacin Parentral J01MA 12 3.11 
Norfloxacin Oral J01MA 06 2.92 
Ofloxacin Oral J01MA 01 2.37 
Total  33.55 
 
The Prescribed Daily Doses of FQs were compared with 
the Defined Daily Doses indexed in the WHO 
Collaborating Centre for Drug Statistics Methodology 
(ATC/DDD Index 2013). We have observed the Prescribed 
Daily Doses, which are same for all the class of FQs 
except Ciprofloxacin. The Prescribed Daily Doses of 
Ciprofloxacin for parenteral route was 0.4 G whereas the 
Defined Daily Dose Ciprofloxacin for parenteral route was 
found to be 0.5 G according to WHO Collaborating Centre 
for Drug Statistics Methodology (ATC/DDD Index 2013). 
This was mainly because, the Inj. Ciprofloxacin 100 ml 
which contains Ciprofloxacin 200 mg which was 
prescribed twice daily. The comparison detail of 
Prescribed Daily Dose with Defined Daily Dose is 
presented in (Table 6). 
 
Table 6: Comparison of Prescribed Daily Doses with Defined Daily Doses 
ATC Code Fluroquinolone PDD Units Rout of administration DDD Units 
J01MA01 Ofloxacin 0.4 
0.4 
G 
G 
Parentral 
Oral 
0.4 
0.4 
G 
G 
J01MA02 Ciprofloxacin 0.4 
1 
G 
G 
Parentral 
Oral 
0.5 
1 
G 
G 
J01MA06 Norfloxacin 0.8 G Oral 0.8 G 
J01MA12 Levofloxacin 0.5 
0.5 
G 
G 
Parentral 
Oral 
0.5 
0.5 
G 
G 
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DISCUSSION: 
All the FQs were prescribed by their brand names. It was 
also seen that the less costly standard brands were used. 
The maximum number of patients (67%) who received 
FQs was admitted in the Medicine wards, the rest (33%) 
were admitted in the Surgery wards. 
In our study Ciprofloxacin was the most frequently 
prescribed FQ followed by Levofloxacin. This was in 
contrast to the study conducted in the United States where 
it was observed that there is an increase in the usage of 
Levofloxacin
6
. In our study DDD/100 bed-days for FQs 
was found to be 33.55. The DDD/100 bed-days of 
Ciprofloxacin and Levofloxacin was found to be 15.72 and 
12.54 respectively. This indicates the highest utilization of 
Ciprofloxacin followed by Levofloxacin within the 
Medicine and Surgery wards of the hospital. A study 
conducted Gordana P et al, concluded that the overall FQ 
utilization was found to be 29.81 DDD/100 bed-days7. In 
another study it was found that parenteral ciprofloxacin 
was prescribed (82.643 DDD/100 BD) and parenteral 
Levofloxacin was prescribed (3.188 DDD/100 BD)
8
. In 
our study we found that parenteral Ciprofloxacin was (2.53 
DDD/100 BD) whereas parenteral Levofloxacin prescribed 
was (3.11 DDD/100 BD).  
During the study period one patient of age 15 years was 
found to be prescribed with FQs. A research on safety and 
efficacy of Ciprofloxacin in children in developing 
countries was reviewed by Green S et al, and they 
concluded that Ciprofloxacin was safe and efficacious9. 
However, it is better to be cautious while prescribing FQs 
in children due to conflicting reports.  In our study 
location, there are no set of criteria for prescribing FQs in 
children and the decision to include the drug in the 
prescription is left to the individual physician. 
Among the study population, we noticed 35 patients, who 
received FQs empirically. The most common clinical 
conditions, that are treated empirically with FQs were 
acute gastroenteritis [15 (42.86%)], lower respiratory tract 
infections [06 (17.14%)] etc.  
In an American study report, FQs were found to be the 
commonly prescribed drug for UTIs, sinusitis, skin 
infections and urinary tract infections6. In a previous study 
it was observed that Ciprofloxacin was mainly used to treat 
conditions like UTIs, chest infections, bacterial 
gastroenteritis, and bacteraemia10. 
CONCLUSION: 
The most common FQs prescribed were found to be 
Ciprofloxacin followed by Levofloxacin. We have 
observed the utilization of quinolone was higher than those 
reported in previous studies whereas the parenteral FQ 
utilization was less than those reported in previous studies. 
This is a good sign as injections are expensive, need of 
trained manpower and may also carry the risk of 
transmission of infections. We suggest that there is also a 
need of guidelines and policies regarding the use of FQs. 
This will effectively minimize the errors on the use of 
antibiotics which may promote rational drug use and better 
care on patients. 
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